Corona-Virus

13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak

Airlines, hotels, casinos and stocks linked to Wuhan, China, continue to fall as fear of the coronavirus deters international travel and all but halts activity in the virus epicenter. Auto companies have suspended business travel to the affected region, and cruise lines are turning away ill guests.

But one sector, in particular, could profit from the outbreak.


Alpha Pro Tech, Ltd. (NYSE: APT) manufactures masks and protective apparel — goods already in high demand in China. Bulk orders are expected as the disease progresses.



Lakeland Industries, Inc. (NASDAQ: LAKE) also produces protective clothes for high-risk workers, such as the medical professionals and public health officials exposing themselves to patients.



Utah medtech company Co-Diagnostics Inc (NASDAQ: CODX) is developing a test for the new coronavirus strain.



The portfolio of Vir Biotechnology Inc (NASDAQ: VIR) includes an antibody for another coronavirus strain, but management is testing to determine efficacy on the Wuhan strain.



BioCryst Pharmaceuticals, Inc.'s (NASDAQ: BCRX) galidesivir is in a Phase 1 study for a range of viruses, including coronaviruses.



Inovio Pharmaceuticals Inc (NASDAQ: INO) is developing a vaccine to treat the MERS strain of coronavirus. While the drug has passed only Phase 1 benchmarks, management may be able to contribute its research toward the Wuhan coronavirus effort.



NanoViricides Inc (NYSE: NNVC) produces nan-medicines to fight virus such as swine flu and bird flu. It also has early-stage programs for Dengue viruses and Ebola and once dabbled in a MERS candidate.